Bharat Biotech seeks trial for intranasal COVID-19 vaccine booster
BENGALURU (Reuters) – Indian vaccine maker Bharat Biotech said on Monday it has submitted an application to the country’s drug regulator to conduct a late-stage trial for a booster dose of its intranasal COVID-19 vaccine. Indian COVID-19 vaccine makers are lobbying the government to authorise boosters as supplies have far outstripped demand, but the health …
Bharat Biotech seeks trial for intranasal COVID-19 vaccine booster Read More »